Please login to the form below

Not currently logged in
Email:
Password:

Arrowhead Therapeutics

This page shows the latest Arrowhead Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Amgen takes aim at cardio diseases with Arrowhead RNAi deal

Amgen takes aim at cardio diseases with Arrowhead RNAi deal

Amgen has bolstered its cardiovascular pipeline by licensing two gene silencing therapies developed by Arrowhead Therapeutics in a deal valued at up to $670m. ... RNA interference (RNAi) specialist Arrowhead pockets $56.5m upfront with another $617m in

Latest news

  • Oncology bias in pharma deals

    Through this deal,  Arrowhead is now a fully integrated RNAi therapeutics developer with three primary siRNA formats. ... disease) to Newron Pharmaceuticals, triggered the termination of Biotie Therapeutics' acquisition of Newron.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during December 2012 Pharma deals during December 2012

    cancer. Finally whilst in California it should be mentioned that Shire has closed a $32.8m research and licence agreement with Arrowhead for research of peptide-targeted therapeutics for rare diseases. ... Commercial deals bring an early Christmas to

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics